Max Ernst Scheulen

机构：West German Heart and Vascular Center Essen, University of Duisburg-Essen

发表论文 283 篇 · 总被引 7286 次 · h-index 39

代表论文

• A randomised, double-blind, placebo-controlled trial of trametinib, an oral MEK inhibitor, in combination with gemcitabine for patients with untreated metastatic adenocarcinoma of the pancreas (2014 · European Journal of Cancer · 被引 377)
• Regorafenib (BAY 73-4506) in advanced colorectal cancer: a phase I study (2012 · British Journal of Cancer · 被引 254)
• Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial (2014 · Annals of Oncology · 被引 152)
• Resminostat plus sorafenib as second-line therapy of advanced hepatocellular carcinoma – The SHELTER study (2016 · Journal of Hepatology · 被引 140)
• Relationship between baseline hepatic status and outcome, and effect of sorafenib on liver function: SHARP trial subanalyses (2012 · Journal of Hepatology · 被引 120)
• Bioequivalence of Liposome-Entrapped Paclitaxel Easy-To-Use (LEP-ETU) Formulation and Paclitaxel in Polyethoxylated Castor Oil: A Randomized, Two-Period Crossover Study in Patients With Advanced Cancer (2013 · Clinical Therapeutics · 被引 89)